Morris Birnbaum, MD, PhD, is Senior Vice President and Chief Scientific Officer for the Internal Medicine Research Unit, comprising Cardiovascular and Metabolic Disease as well as Neuroscience research. Dr. Birnbaum completed his undergraduate, graduate, and medical training at Brown University in Providence, Rhode Island before moving to St. Louis to carry out clinical training in Internal Medicine at Barnes Hospital of Washington University School of Medicine. He then performed postdoctoral studies at the University of California, San Francisco and Sloan-Kettering Cancer Institute. Following an associate professorship in the Department of Cell Biology at Harvard Medical School.
Morris Birnbaum the study of insulin action, metabolism and how organisms respond to both a deficit and a surfeit of food, discovery of novel transformative therapies to reduce the prevalence of cardio metabolic dysfunction, thereby eliminating or diminishing the impact of heart diseases on life expectancy and quality.